Breaking News Instant updates and real-time market news.

FB

Facebook

$134.76

2.285 (1.72%)

17:42
11/21/18
11/21
17:42
11/21/18
17:42

Facebook says it asked Definers to do work on Soros, competitors

Facebook said in a blog post that yesterday outgoing Head of Communications and Policy Elliot Schrage shared more detail with the company's employees about the work it did with Definers, a Washington, DC PR firm. "We hired Definers in 2017 as part of our efforts to diversify our DC advisors after the election," Facebook said. "Like many companies, we needed to broaden our outreach. We also faced growing pressure from competitors in tech, telcos and media companies that want government to regulate us. This pressure became particularly acute in September 2017 after we released details of Russian interference on our service. We hired firms associated with both Republicans and Democrats - Definers was one of the Republican-affiliated firms. While we're continuing to review our relationship with Definers, we know the following: We asked Definers to do what public relations firms typically do to support a company - sending us press clippings, conducting research, writing messaging documents, and reaching out to reporters. Some of this work is being characterized as opposition research, but I believe it would be irresponsible and unprofessional for us not to understand the backgrounds and potential conflicts of interest of our critics. This work can be used internally to inform our messaging and where appropriate it can be shared with reporters. This work is also useful to help respond to unfair claims where Facebook has been singled out for criticism, and to positively distinguish us from competitors. As the pressure on Facebook built throughout the year, the Communications team used Definers more and more. At Sheryl's request, we're going through all the work they did, but we have learned that as the engagement expanded, more people worked with them on more projects and the relationship was less centrally managed." Facebook said it did ask Definers to do work on George Soros, saying it wanted to determine if Soros had any financial motivation to call the company a "menace to society." The company added that it did ask Definers to do work on its competitors, though it did not ask them to create or distribute fake news. "Responsibility for these decisions rests with leadership of the Communications team," Schrage said. "That's me. Mark and Sheryl relied on me to manage this without controversy." "Mark has asked us to reevaluate how we work with communications consultants. It's not about Definers. It is about us, not them," Schrage added. Reference Link

  • 28

    Nov

FB Facebook
$134.76

2.285 (1.72%)

11/08/18
DADA
11/08/18
NO CHANGE
Target $42
DADA
Buy
Applied Optoelectronics price target raised to $42 from $36 at DA Davidson
DA Davidson analyst Mark Kelleher raised his price target on Applied Optoelectronics (AAOI) to $42 and kept his Buy rating after its Q3 results, saying that despite the earnings shortfall, the company remains among the "leading providers of optical networking technology to the datacenter and cable TV markets". The analyst notes that the company had already negatively preannounced Q3 on sales impact from the issue found with a small percentage of its 25G lasers, but that issue had been resolved and shipments to the impacted customer - Facebook (FB) - have resumed.
11/13/18
OPCO
11/13/18
NO CHANGE
Target $16
OPCO
Outperform
EverQuote price target lowered to $16 from $23 at Oppenheimer
Oppenheimer analyst Jason Helfstein lowered his price target for EverQuote (EVER) to $16 from $23 after management lowered 2018 VMM guidance 5% on less effective traffic conversion from creative advertisement fatigue, adjusting to new Facebook (FB) ad policies, and pushing higher volumes to providers in lower seasonal period. The analyst reiterates an Outperform rating on EverQuote on favorable risk/reward for long-term opportunity to penetrate $9B insurance advertising market.
11/13/18
ADAM
11/13/18
NO CHANGE
Target $18
ADAM
Buy
EverQuote price target lowered to $18 from $23 at Canaccord
Canaccord analyst Michael Graham lowered his price target on EverQuote (EVER) to $18 from $23 following in line Q3 results. The company said quote requests declined from the revamp of its ad units in the face of policy changes at Facebook (FB) along with the crowding out from political ads. Management said they see the same circumstances affecting business so far in Q4. Graham maintained his Buy rating on EverQuote shares.
11/16/18
STFL
11/16/18
NO CHANGE
STFL
Buy
Facebook path to rebuild credibility 'long and difficult,' says Stifel
Stifel analyst Scott Devitt said the probability of change at the top of Facebook is low, given that Mark Zuckerberg controls the majority of Facebook voting power, but Devitt believes the "campaign trail to rebuild credibility will be long and difficult" following the recent critical articles in The New York Times and Wall Street Journal. Facebook's board and management could accelerate the credibility rebuild by considering making a or changes at the top, which Devitt thinks would be viewed positively "by the vast majority of constituents." The analyst maintains a Buy rating on Facebook shares.

TODAY'S FREE FLY STORIES

AUPH

Aurinia Pharmaceuticals

$6.44

0.17 (2.71%)

15:34
03/19/19
03/19
15:34
03/19/19
15:34
Options
Aurinia Pharmaceuticals options imply 15.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

FB

Facebook

$161.69

1.23 (0.77%)

15:32
03/19/19
03/19
15:32
03/19/19
15:32
Hot Stocks
Facebook settles discriminatory advertising lawsuits »

Facebook COO Sheryl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

LXRX

Lexicon

$7.79

0.18 (2.37%)

15:30
03/19/19
03/19
15:30
03/19/19
15:30
Options
Call buyer opens a bullish position in Lexicon Pharmaceuticals upside calls »

Call buyer opens a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 25

    Apr

HRTX

Heron Therapeutics

$24.70

0.28 (1.15%)

15:20
03/19/19
03/19
15:20
03/19/19
15:20
Options
6X average daily option volume in Heron Therapeautics driven by call spreads »

6X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

HNP

Huaneng Power

$23.42

-0.47 (-1.97%)

15:19
03/19/19
03/19
15:19
03/19/19
15:19
Downgrade
Huaneng Power rating change  »

Huaneng Power downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$43.88

0.21 (0.48%)

15:19
03/19/19
03/19
15:19
03/19/19
15:19
Options
Smartsheet options imply 12.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 05

    Apr

VALE

Vale

$13.90

0.62 (4.67%)

15:18
03/19/19
03/19
15:18
03/19/19
15:18
Hot Stocks
Vale reports reestablishment of Guaiba Island Terminal activities »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
03/19/19
03/19
15:17
03/19/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
03/19/19
03/19
15:16
03/19/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.24

0.54 (2.38%)

15:10
03/19/19
03/19
15:10
03/19/19
15:10
Conference/Events
Mallinckrodt management to meet with Mizuho »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

SYMC

Symantec

$23.27

0.19 (0.82%)

15:10
03/19/19
03/19
15:10
03/19/19
15:10
Options
Put buyers sizing up new positions in Symantec far downside strikes »

Put buyers sizing up new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

GATX

GATX

$76.90

0.21 (0.27%)

15:08
03/19/19
03/19
15:08
03/19/19
15:08
Conference/Events
GATX management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

BA

Boeing

$375.00

2.9 (0.78%)

15:08
03/19/19
03/19
15:08
03/19/19
15:08
Periodicals
DOT asks department watchdog to audit approval of Boeing 737, Bloomberg says »

Transportation Secretary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

BA

Boeing

$375.07

2.97 (0.80%)

15:05
03/19/19
03/19
15:05
03/19/19
15:05
Periodicals
Breaking Periodicals news story on Boeing »

DOT asks Inspector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

TME

Tencent Music

$19.33

0.2 (1.05%)

15:04
03/19/19
03/19
15:04
03/19/19
15:04
Options
Tencent options imply 12.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

NAII

Natural Alternatives International

$11.20

-0.17 (-1.50%)

15:01
03/19/19
03/19
15:01
03/19/19
15:01
Hot Stocks
Natural Alternatives says Court of Appeals rules in its favor in patent suit »

Natural Alternatives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
03/19/19
03/19
15:00
03/19/19
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

KEM

Kemet

$18.34

0.02 (0.11%)

14:56
03/19/19
03/19
14:56
03/19/19
14:56
Conference/Events
Kemet management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

DBD

Diebold

$11.07

-0.33 (-2.89%)

14:55
03/19/19
03/19
14:55
03/19/19
14:55
Options
Diebold put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$25.68

2.43 (10.45%)

, GOOG

Alphabet

$1,195.81

12.15 (1.03%)

14:54
03/19/19
03/19
14:54
03/19/19
14:54
Hot Stocks
AMD says Radeon GPUs being used for Google Stadia platform »

AMD (AMD) announced that…

AMD

AMD

$25.68

2.43 (10.45%)

GOOG

Alphabet

$1,195.81

12.15 (1.03%)

GOOGL

Alphabet Class A

$1,199.72

11.63 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

SIEN

Sientra

$9.26

0.05 (0.54%)

14:51
03/19/19
03/19
14:51
03/19/19
14:51
Hot Stocks
Breaking Hot Stocks news story on Sientra »

Sientra down 6% after FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WNS

WNS Holdings

$52.87

-0.14 (-0.26%)

14:50
03/19/19
03/19
14:50
03/19/19
14:50
Conference/Events
WNS Holdings management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 26

    Mar

JCOM

j2 Global

$86.67

0.76 (0.88%)

14:49
03/19/19
03/19
14:49
03/19/19
14:49
Conference/Events
j2 Global management to meet with Wedbush »

Luncheon and Dinner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

FDX

FedEx

$182.02

-0.4 (-0.22%)

14:49
03/19/19
03/19
14:49
03/19/19
14:49
Options
Fedex options imply 8.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

SIEN

Sientra

$9.26

0.05 (0.54%)

14:48
03/19/19
03/19
14:48
03/19/19
14:48
Hot Stocks
FDA posts warning letter sent to Sientra »

In a letter dated March…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.